platelet ADP receptor program (Millennium)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameplatelet ADP receptor program (Millennium)
Drug Alias NameP2Y12 receptor antagonists (Millennium)platelet aggregation inhibitor (Millennium)P2Y12 receptor antagonists (COR Therapeutics Inc)CT-50547
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsThrombosisMyocardial InfarctionStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCor Therapeutics IncMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial InfarctionStroke

Other Information

ATC CodeN/A
Related LinksN/A